Opsoclonus myoclonus syndrome in two cases with neuroborreliosis.
Skeie
G O
GO
Eldøen
G
G
Skeie
B S
BS
Midgard
R
R
Kristoffersen
E K
EK
Bindoff
L A
LA
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000906:Antibodies / Q000097:blood / Q000134:cerebrospinal fluid; D001259:Ataxia / Q000382:microbiology / Q000503:physiopathology; D025065:Borrelia burgdorferi / Q000276:immunology; D001921:Brain / Q000382:microbiology / Q000503:physiopathology; D002443:Ceftriaxone / Q000008:administration & dosage; D005260:Female; D006801:Humans; D020852:Lyme Neuroborreliosis / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D008279:Magnetic Resonance Imaging; D009325:Nausea / Q000209:etiology; D019547:Neck Pain / Q000382:microbiology; D009664:Norway; D053578:Opsoclonus-Myoclonus Syndrome / Q000175:diagnosis* / Q000382:microbiology* / Q000503:physiopathology; D013995:Time; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000906:Antibodies; D002443:Ceftriaxone